Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
WEX Inc. (WEX)
NYSEFinancialsSoftware - InfrastructureSnapshot 2026-11-04
$180.11-1.02%
Close 2026-11-04 · 1-day change
NYSEFinancialsSoftware - InfrastructureSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
21.24 → 22.55 EPS · FY ending Dec 31, 2027 · 11 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 11 to 11; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for WEX yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
EPS near $19.25 in FY26 | A primary condition in WEX Inc.'s published investment case. The stated target is ~19.25 USD per share. | Intact | EPS falls below $18.95 in FY26 | Diluted EPS: $3.88 per share FY2026-Q3; GAAP. Published target: ~19.25 USD per share. Annual target cannot be compared with a quarterly or TTM observation. Oct 29, 20263.88 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
WEX is a financially strong recent performer with a core-growth and innovation strategy, rather than a turnaround story. Its long-term thesis is intact, but earnings quality is fragile and the latest quarter brought an earnings miss.
The valuation evidence is mixed: WEX is described as cheap versus peers, while the overall value assessment is expensive. The expectations gap is modestly negative, and the priced-in assessment says current fragility is low and the valuation is justified, not a full combination of expensive, weak, and turbulent conditions.
Near-term results show strong revenue growth, including higher Mobility revenue, and leverage declined from 3.1x in Q1 to 2.7x in Q3. Management has kept its core-growth priorities consistent, but the recent earnings miss and a run of misses among the company and industry peers make execution quality a concern.
The multi-year view depends on WEX sustaining core growth, continuing to reduce leverage, and maintaining credibility after raising guidance in July. Near-term risks include another guidance reversal and rate cuts; continued earnings strength from sector peers could support the sector backdrop.
The 1-to-3-year thesis remains intact, supported by recent operating momentum and progress on leverage, but fragile earnings quality and the latest miss leave meaningful execution risk. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Management is focused on expanding the core business and innovation. |
| Intact |
| Progress score falls below 70% |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 4 of 4 supplied quarters. Management reported: “• For the full year 2026, the Company now expects revenue in the range of $2.86 billion to $2.90 billion and adjusted net income in the range of $689 million to $703 million, or $19.68 to $20.08 per diluted share, compared to previous guidance for revenue of $2.82 billion to $2.88 billion and adjusted net income of $667 million to $688 million, or $18.95 to $19.55 per diluted share.” “We’re building on that momentum by continuing to strengthen our segments, bring innovative solutions to market, and drive sustainable growth and long-term shareholder value.”” Revenue was $780.100 million in 2026-Q3. Delivery assessment Nov 4, 2026 |
Revenue growth at or above 5% annually | A primary condition in WEX Inc.'s published investment case. The stated target is >=5% YoY. | Under Pressure | YoY revenue growth falls below 5% in FY26 | Revenue growth: 12.76% FY2026-Q3; GAAP. Published target: >=5% YoY. Annual target cannot be compared with a quarterly or TTM observation. Oct 29, 202612.763805 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 4 of 4 supplied quarters. Management reported: “• For the full year 2026, the Company now expects revenue in the range of $2.86 billion to $2.90 billion and adjusted net income in the range of $689 million to $703 million, or $19.68 to $20.08 per diluted share, compared to previous guidance for revenue of $2.82 billion to $2.88 billion and adjusted net income of $667 million to $688 million, or $18.95 to $19.55 per diluted share.” “We’re building on that momentum by continuing to strengthen our segments, bring innovative solutions to market, and drive sustainable growth and long-term shareholder value.”” Revenue was $780.100 million in 2026-Q3. Delivery assessment Nov 4, 2026 |
Execute $1 billion share repurchase program | The company is buying back up to $1 billion in stock, which supports the share price. | Intact | Buyback program is cancelled or materially delayed | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$20.43 → $22.55 · observed estimates
$2.93B → $3.05B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $20.43 | $2,928,396,610 | 14 / 13 |
| 2026-07-25 | $20.91 | $2,927,677,180 | 14 / 14 |
| 2026-07-26 | $20.91 | $2,927,677,180 | 14 / 14 |
| 2026-07-27 | $21.01 | $2,928,311,720 | 10 / 11 |
| 2026-07-28 | $21.01 | $2,928,311,720 | 10 / 11 |
| 2026-07-29 | $21.13 | $2,930,111,720 | 10 / 12 |
| 2026-07-30 | $21.13 | $2,930,111,720 | 10 / 12 |
| 2026-07-31 | $21.13 | $2,930,111,720 | 10 / 12 |
| 2026-08-01 | $21.13 | $2,930,111,720 | 10 / 12 |
| 2026-08-02 | $21.09 | $2,930,073,450 | 14 / 14 |
| 2026-08-03 | $21.09 | $2,930,073,450 | 14 / 14 |
| 2026-08-04 | $21.09 | $2,930,073,450 | 14 / 14 |
| 2026-08-05 | $21.13 | $2,930,111,720 | 10 / 12 |
| 2026-08-06 | $21.09 | $2,930,073,450 | 14 / 14 |
| 2026-08-08 | $21.13 | $2,930,111,720 | 10 / 12 |
| 2026-08-09 | $21.13 | $2,930,111,720 | 10 / 12 |
| 2026-08-10 | $21.09 | $2,930,073,450 | 14 / 14 |
| 2026-08-12 | $21.13 | $2,930,111,720 | 10 / 12 |
| 2026-08-13 | $21.13 | $2,930,111,720 | 10 / 12 |
| 2026-08-14 | $21.13 | $2,930,111,720 | 10 / 12 |
| 2026-08-15 | $21.13 | $2,930,111,720 | 10 / 12 |
| 2026-08-16 | $21.13 | $2,930,111,720 | 10 / 12 |
| 2026-08-17 | $21.13 | $2,930,111,720 | 10 / 12 |
| 2026-08-18 | $21.13 | $2,930,111,720 | 10 / 12 |
| 2026-08-19 | $21.13 | $2,930,111,720 | 10 / 12 |
| 2026-08-20 | $21.13 | $2,930,111,720 | 10 / 12 |
| 2026-08-21 | $21.13 | $2,930,111,720 | 10 / 12 |
| 2026-08-22 | $21.13 | $2,930,111,720 | 10 / 12 |
| 2026-08-23 | $21.13 | $2,930,111,720 | 10 / 12 |
| 2026-08-24 | $21.13 | $2,930,111,720 | 10 / 12 |
| 2026-08-25 | $21.13 | $2,930,111,720 | 10 / 12 |
| 2026-08-26 | $21.23 | $2,930,111,720 | 10 / 12 |
| 2026-08-27 | $21.23 | $2,930,111,720 | 10 / 12 |
| 2026-08-28 | $21.23 | $2,930,111,720 | 10 / 12 |
| 2026-08-29 | $21.23 | $2,930,111,720 | 10 / 12 |
| 2026-08-30 | $21.23 | $2,930,111,720 | 10 / 12 |
| 2026-08-31 | $21.23 | $2,930,111,720 | 10 / 12 |
| 2026-09-01 | $21.23 | $2,930,111,720 | 10 / 12 |
| 2026-09-02 | $21.23 | $2,930,111,720 | 10 / 12 |
| 2026-09-03 | $21.23 | $2,930,111,720 | 10 / 12 |
| 2026-09-04 | $21.23 | $2,930,111,720 | 10 / 12 |
| 2026-09-05 | $21.23 | $2,930,111,720 | 10 / 12 |
| 2026-09-06 | $21.23 | $2,930,111,720 | 10 / 12 |
| 2026-09-07 | $21.23 | $2,930,111,720 | 10 / 12 |
| 2026-09-08 | $21.23 | $2,930,111,720 | 10 / 12 |
| 2026-09-09 | $21.23 | $2,930,111,720 | 10 / 12 |
| 2026-09-10 | $21.23 | $2,930,111,720 | 10 / 12 |
| 2026-09-11 | $21.23 | $2,930,111,720 | 10 / 12 |
| 2026-09-12 | $21.23 | $2,931,237,605 | 11 / 12 |
| 2026-09-13 | $21.23 | $2,931,237,605 | 11 / 12 |
| 2026-09-14 | $21.23 | $2,931,237,605 | 11 / 12 |
| 2026-09-15 | $21.23 | $2,931,237,605 | 11 / 12 |
| 2026-09-16 | $21.23 | $2,931,237,605 | 11 / 13 |
| 2026-09-17 | $21.23 | $2,931,237,605 | 11 / 13 |
| 2026-09-18 | $21.23 | $2,931,237,605 | 11 / 13 |
| 2026-09-19 | $21.23 | $2,931,237,605 | 11 / 13 |
| 2026-09-20 | $21.23 | $2,931,237,605 | 11 / 13 |
| 2026-09-21 | $21.23 | $2,931,237,605 | 11 / 13 |
| 2026-09-22 | $21.23 | $2,931,237,605 | 11 / 13 |
| 2026-09-23 | $21.23 | $2,931,237,605 | 11 / 13 |
| 2026-09-24 | $21.23 | $2,931,237,605 | 11 / 13 |
| 2026-09-25 | $21.24 | $2,932,477,605 | 11 / 13 |
| 2026-09-26 | $21.24 | $2,932,477,605 | 11 / 13 |
| 2026-09-27 | $21.24 | $2,932,477,605 | 11 / 13 |
| 2026-09-28 | $21.24 | $2,932,477,605 | 11 / 13 |
| 2026-09-29 | $21.24 | $2,932,477,605 | 11 / 13 |
| 2026-09-30 | $21.24 | $2,932,477,605 | 11 / 13 |
| 2026-10-01 | $21.24 | $2,932,477,605 | 11 / 13 |
| 2026-10-02 | $21.24 | $2,932,477,605 | 11 / 13 |
| 2026-10-03 | $21.24 | $2,932,477,605 | 11 / 13 |
| 2026-10-04 | $21.24 | $2,932,477,605 | 11 / 13 |
| 2026-10-05 | $21.24 | $2,932,477,605 | 11 / 13 |
| 2026-10-06 | $21.24 | $2,932,477,605 | 11 / 13 |
| 2026-10-07 | $21.29 | $2,932,477,605 | 11 / 13 |
| 2026-10-08 | $21.29 | $2,932,477,605 | 11 / 13 |
| 2026-10-09 | $21.34 | $2,939,837,605 | 11 / 13 |
| 2026-10-10 | $21.34 | $2,939,837,605 | 11 / 13 |
| 2026-10-11 | $21.34 | $2,939,837,605 | 11 / 13 |
| 2026-10-12 | $21.34 | $2,939,837,605 | 11 / 13 |
| 2026-10-13 | $21.34 | $2,939,837,605 | 11 / 13 |
| 2026-10-14 | $21.34 | $2,939,811,859 | 11 / 13 |
| 2026-10-15 | $21.34 | $2,939,811,859 | 11 / 13 |
| 2026-10-16 | $21.34 | $2,939,811,859 | 11 / 13 |
| 2026-10-17 | $21.34 | $2,939,811,859 | 11 / 13 |
| 2026-10-18 | $21.36 | $2,943,559,566 | 11 / 13 |
| 2026-10-19 | $21.36 | $2,943,559,566 | 11 / 13 |
| 2026-10-20 | $21.36 | $2,943,559,566 | 11 / 13 |
| 2026-10-21 | $21.36 | $2,943,559,566 | 11 / 13 |
| 2026-10-22 | $21.35 | $2,941,559,566 | 11 / 13 |
| 2026-10-23 | $21.35 | $2,941,559,566 | 11 / 13 |
| 2026-10-24 | $21.35 | $2,941,559,566 | 11 / 13 |
| 2026-10-25 | $21.35 | $2,941,559,566 | 11 / 13 |
| 2026-10-26 | $21.35 | $2,941,559,566 | 11 / 13 |
| 2026-10-27 | $21.35 | $2,941,559,566 | 11 / 13 |
| 2026-10-28 | $21.40 | $2,952,817,725 | 11 / 13 |
| 2026-10-29 | $21.40 | $2,952,843,471 | 11 / 13 |
| 2026-10-30 | $21.97 | $3,014,383,885 | 11 / 13 |
| 2026-10-31 | $22.22 | $3,029,262,912 | 11 / 11 |
| 2026-11-01 | $22.22 | $3,029,262,912 | 11 / 11 |
| 2026-11-02 | $22.22 | $3,029,262,912 | 11 / 11 |
| 2026-11-03 | $22.56 | $3,050,343,930 | 11 / 12 |
| 2026-11-04 | $22.55 | $3,050,343,930 | 11 / 13 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 5 Buy / Strong Buy · 10 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 3 recorded
1 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.